Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

Antibody Engineering & Therapeutics Asia

$500 SAVINGS END IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
19 - 21 October, 2026
The Westin Miyako KyotoKyoto, Japan

Philip Kim, PhD
Professor, University of Toronto & CTO and Co-Founder at Fable Therapeutics, Canada
Speaker

Profile

Philip M. Kim is a professor at the University of Toronto at the Donnelly Centre and the Departments of Computer Science and Molecular Genetics. In his academic research, he has been developing novel machine learning methods for protein and peptide engineering and authored over 90 publications, 7 invention disclosures and 5 patent applications. He has co-founded several biotechnology companies and serves as consultant and member of the scientific advisory board for others. Before setting up his lab in 2009, he was a postdoctoral fellow at Yale University and an associate with McKinsey & Co. He holds a Ph.D. from the Artificial Intelligence Laboratory and Department of Chemistry at the Massachusetts Institute of Technology and a B.S. in Physics and Biochemistry from the University of Tuebingen.

Agenda Sessions

  • Physics aware machine learning methods for modeling dynamics, expansion of chemical space and the design of intracellular biologics

    17:00